<DOC>
	<DOCNO>NCT00663351</DOCNO>
	<brief_summary>This Post-Approval study prospective follow-up study design evaluate long-term safety effectiveness Reflection Ceramic Acetabular System .</brief_summary>
	<brief_title>Safety Effectiveness Study Reflection Ceramic Acetabular System</brief_title>
	<detailed_description>This Post-Approval study prospective follow-up study design evaluate long-term safety effectiveness Reflection Ceramic Acetabular System . Randomized Non-inflammatory Arthritis , Randomized Inflammatory Continued Access Cohorts patient previously enrol IDE study evaluate annually five ( 5 ) year follow-up . In addition , patient enrol original study cohort well continued access patient send letter questionnaire annually 6-10 year postoperative time point assess patient 's general well-being study component still place</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Criteria ( Patient must meet follow characteristic enrol study ) : Males female , 21 80 year age , inclusive ; Primary diagnosis noninflammatory arthritis ( osteoarthritis ) inflammatory arthritis ( rheumatoid arthritis ) , patient require revision specify previously ; The patient his/her legal guardian willing consent participate study sign date approved consent form ; The patient available followup least two year postoperative ; The patient meet acceptable preoperative medical clearance free treat cardiac , pulmonary , hematological , etc. , condition would pose excessive operative risk ( FDA requirement ) ; The patient total Harris Hip Score less equal 60 ( FDA requirement ) ; The patient meet none exclusion criterion . ( Patient follow characteristic must exclude study ) : Patients know insufficient quantity quality bone support result Conditions cancer , femoral osteotomy , Girdlestone resection , significant osteoporosis metabolic disorder calcify tissue . Patients physical condition tend place extreme load implant morbid obesity ( &gt; 100 pound desirable body weight ) , Charcot joint , muscle deficiency , multiple joint disability ; Patients active localized systemic infection ; Patients reach full skeletal maturity ; Patient psychological neurological condition tend preempt patient 's ability willingness restrict activity follow medical advice , especially postoperative period , e.g . : drug alcohol abuse , serious mental illness retardation , general neurological condition ; The patient participate pharmaceutical , biologic medical device clinical investigation ; Immunosuppressive disorder immunosuppressive disorder chronic condition characterize markedly inhibited ability respond antigenic stimulus . Examples condition include patient immunosuppressive therapy ( corticosteroid hormone large amount , cytotoxic drug , antilymphocytic serum irradiation large dos ) , patient receive therapy prevent homograft rejection , patient acquire immunodeficiency syndrome ( AIDS ) , autoimmune disease ( except rheumatoid arthritis ) . Pregnancy . Patients known sensitivity material device .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Arthritis</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Traumatic Arthritis</keyword>
	<keyword>Degenerative Joint Disease</keyword>
	<keyword>Avascular Necrosis</keyword>
</DOC>